Synergistic Combinations for Autoimmune Disease Prevention and Treatment

Publication ID: 24-11857563_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Combinations for Autoimmune Disease Prevention and Treatment,” Published Technical Disclosure No. 24-11857563_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857563_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,563.

Summary of the Inventive Concept

The inventive concept integrates the original patented method for targeting pathogenic age-associated B cells with distinct technologies such as AI, IoT, blockchain, and new materials to create a more powerful system for diagnosing, preventing, and treating autoimmune diseases.

Background and Problem Solved

The original patent provides a method for treating autoimmune diseases by targeting pathogenic age-associated B cells. However, the patent has limitations in terms of diagnosis, prevention, and treatment. The new inventive concept addresses these limitations by combining the original method with advanced technologies to create a more comprehensive and effective system.

Detailed Description of the Inventive Concept

The inventive concept comprises five synergistic combinations: 1) a machine learning model and blockchain-based secure data storage system for diagnosing autoimmune diseases, 2) a method for preventing autoimmune disease using IoT-enabled wearable devices, 3) a nanoparticle-based delivery system and graphene-based sensor for treating lymphoproliferative disorders, 4) a deep learning model and cloud-based computing platform for predicting autoimmune disease risk, and 5) a natural language processing-based AI system and CRISPR-Cas9-based gene editing system for identifying novel therapeutic targets.

Novelty and Inventive Step

The new claims introduce novel combinations of the original patented method with advanced technologies, providing a more comprehensive and effective system for diagnosing, preventing, and treating autoimmune diseases. The inventive step lies in the unexpected integration of these distinct technologies to create a synergistic system that overcomes the limitations of the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using different machine learning models, blockchain platforms, or IoT devices. Variations could include applying the system to different autoimmune diseases or using different nanoparticle-based delivery systems.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the healthcare industry, particularly in the fields of autoimmune disease diagnosis, prevention, and treatment. The market for autoimmune disease treatments is projected to grow significantly in the coming years, and the inventive concept is well-positioned to capitalize on this trend.

Original Patent Information

Patent NumberUS 11,857,563
TitleInhibition of expansion and function of pathogenic age-associated B cells and use for the prevention and treatment of autoimmune disease
Assignee(s)NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED, MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY